Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Mesothelioma × Folic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Polycystic Ovary Syndrome 16 Carcinoma, Non-Small-Cell Lung 12 Colorectal Neoplasms 10 Lung Neoplasms 8 Recurrence 6 Neoplasm Metastasis 5 Colonic Neoplasms 5 Rectal Neoplasms 4 Breast Neoplasms 4 Neoplasms 3 Lymphoma, T-Cell, Peripheral 3 Infertility 3 Urinary Bladder Neoplasms 2 Sezary Syndrome 2 Papillomavirus Infections 2 Ovarian Neoplasms 2 Mycosis Fungoides 2 Meningeal Carcinomatosis 2 Lymphoma, T-Cell, Cutaneous 2 Lymphoma, T-Cell 2 Insulin Resistance 2 Infertility, Female 2 Hyperandrogenism 2 Head and Neck Neoplasms 2 Diabetes, Gestational 2 Carcinoma, Transitional Cell 2 Atypical Squamous Cells of the Cervix 2 Anovulation 2 Adenoma 2 Uterine Cervical Neoplasms 1

Interventions

Pemetrexed 34 Cisplatin 28 pembrolizumab 19 Nivolumab 15 Carboplatin 15 Ipilimumab 11 Gemcitabine 9 Cyclophosphamide 7 durvalumab 6 fludarabine 5 Bevacizumab 5 Radiotherapy, Intensity-Modulated 4 Dexamethasone 4 tremelimumab 3 tazemetostat 3 olaparib 3 niraparib 3 anetumab ravtansine 3 Vinorelbine 3 Paclitaxel 3 LMB-100 3 Imatinib Mesylate 3 Cerebral Decortication 3 sargramostim 2 fludarabine phosphate 2 defactinib 2 budigalimab 2 belinostat 2 atezolizumab 2 Vorinostat 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01569919 2013-03-12

SKOPOS

Wales Cancer Trials Unit

Phase 2 Unknown

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡